North America Breast Reconstruction Market
Breast reconstruction is the surgical method of reconstructing the shape and looks of a breast, most generally in women who have had surgery to treat breast cancer. It includes autologous tissue, prosthetic implants, or a mixture of both, to reconstruct a natural-looking breast. Breast reconstruction techniques have developed over the last numerous decades, with options tailored to the individual needs of women with breast cancer.
Thus, the high prevalence of breast cancer is expected to create a significant demand for breast reconstruction in the coming years, which is further anticipated to drive the breast reconstruction market.
The COVID-19 pandemic has impacted breast surgeries also in a pervasive manner. The sudden situation has stimulated breast and plastic surgeons, healthcare decision-makers, and policymakers, who have met with the need to expeditiously implement containment measures to mitigate the impact of the COVID-19 pandemic. Moreover, on March 13th, 2020, the American College of Surgeons (ACS) suggested that hospitals, health institutions, and surgeons across the nation reduce, postpone or cancel electively scheduled operations, including breast reconstruction procedures. The surgeries were canceled to maximize bed space, maintain personal protective equipment, and reduce the risk of transmission amongst patients and providers. Furthermore, the COVID-19 pandemic has undeniably introduced even more panic and fear into the previously anxiety-provoking situation of a breast cancer diagnosis. As per the report published by Anticancer Research in 2021, nearly half (44.2%) of the patients showed that breast reconstruction was not occurring at their institutions during the pandemic, whether that was by a delay of all oncologic treatment hormone/chemotherapy alone or mastectomy alone. In addition, the COVID-19 pandemic is perplexing healthcare institutions in the region with unprecedented operational and clinical challenges. Moreover, the shift of priorities from breast reconstruction to coronavirus diagnosis and treatment devices are leading to a decline in breast reconstruction, leading to a decrease in market growth up to the certain extent.
Strategic insights for the North America Breast Reconstruction provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 312.2 Million |
| Market Size by 2028 | US$ 482.1 Million |
| Global CAGR (2021 - 2028) | 6.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The geographic scope of the North America Breast Reconstruction refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Breast reconstruction market in North America is expected to grow from US$ 312.2 million in 2021 to US$ 482.1 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. Patients undergoing unilateral or bilateral mastectomy procedures usually opt for breast reconstruction for regaining the original shape of the breasts and improving their aesthetic appeal, among other factors. Thus, it is important for the market players to come up with innovative products that would marginally boost the adoption of this procedure. Tissue expander is one such innovation that eases the task of surgeons and improves the effectiveness of the reconstruction procedures. In December 2016, the US Food and Drug Administration (FDA) approved the marketing of the AeroForm tissue expander offered by AirXpanders; it is a needle-free alternative for patients undergoing breast reconstruction procedure. Moreover, in April 2018, Sientra, Inc. showcased its modern breast implants at the American Society of Aesthetic Plastic Surgeons Meeting 2018. In September 2020, POLYTECH Health & Aesthetics GmbH announced the launch of its expanded B-Lite portfolio, which is consists of the world's first and only lightweight breast implants. Thus, the capitalization in innovative technologies to come up with breakthrough products is emerging a s key opportunity for the breast construction market players to secure high revenues and marginal profits in the coming years.
In terms of technology, the inframammary segment accounted for the largest share of the North America breast reconstruction market in 2020. In terms of type, the breast implants segment accounted for the largest share of the North America breast reconstruction market in 2020. In terms of placement, the dual plane insertion segment accounted for the largest share of the North America breast reconstruction market in 2020. In terms of procedure, the immediate procedures segment held a larger market share of the breast reconstruction market in 2020.
A few major primary and secondary sources referred to for preparing this report on the breast reconstruction market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc
By Technology
By Type
By Placement
By Procedure
By Country
The North America Breast Reconstruction Market is valued at US$ 312.2 Million in 2021, it is projected to reach US$ 482.1 Million by 2028.
As per our report North America Breast Reconstruction Market, the market size is valued at US$ 312.2 Million in 2021, projecting it to reach US$ 482.1 Million by 2028. This translates to a CAGR of approximately 6.4% during the forecast period.
The North America Breast Reconstruction Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Breast Reconstruction Market report:
The North America Breast Reconstruction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Breast Reconstruction Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Breast Reconstruction Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Breast Reconstruction Market
